Drug Development in Critical Times

NeuroRX
doi 10.1016/j.nurx.2006.08.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reflecting on Critical Citizenship in Critical Times

2016English

Drug Retention Times

2007English

FDA Critical Path Initiatives: Opportunities for Generic Drug Development

AAPS Journal
Pharmaceutical Science
2008English

Critical Times in Pediatric Out-Of-Hospital Cardiac Arrest

Critical Care
Critical CareIntensive Care Medicine
2012English

Drug-Induced Hyperthermia in Critical Care

Journal of the Intensive Care Society
Critical Care NursingCritical CareIntensive Care Medicine
2015English

Critical Considerations in Anticancer Drug Development and Dosing Strategies: The Past, Present, and Future

Journal of Clinical Pharmacology
Pharmacology
2017English

A Critical View on Human Mobility in Times of Crisis

Global Policy
Planetary ChangeManagementInternational RelationsEconomicsGlobalPolitical SciencePolicyMonitoringLawEconometrics
2017English

Therapeutic Challenges Posed by Critical Drug-Drug Interactions in Cystic Fibrosis

Pediatric Pulmonology
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2016English

Adverse Drug Events in the Critical Care Unit

Critical Care
Critical CareIntensive Care Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy